Gregory T Lucier
CIK 1251299 · View on SEC EDGAR ↗
First SEC filing: June 10, 2026 · Latest: June 10, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | XRAY | P | 15,000 | $12.44 | $186,600 | 65,000 Indirect | +30.00% | Acquired | -12.1% (price as of 2026-08-20) |
| March 3, 2026 | XRAY | P | 22,445 | $14.03 | $314,903 | 50,000 Indirect | +81.46% | Acquired | -22.0% (price as of 2026-08-20) |
| March 2, 2026 | XRAY | P | 27,555 | $14.24 | $392,383 | 27,555 Indirect | — | Acquired | -23.2% (price as of 2026-08-20) |
| Dec. 8, 2025 | XRAY | S | 82,200 | $11.14 | $915,708 | 0 Direct | -100.00% | Disposed | -1.8% (price as of 2026-08-20) |
| Dec. 8, 2025 | MRVI | P | 48,528 | $3.67 | $178,098 | 155,123 Direct | +45.53% | Acquired | 114.9% (price as of 2026-08-20) |
| Dec. 5, 2025 | MRVI | P | 51,472 | $3.70 | $190,446 | 106,595 Direct | +93.38% | Acquired | 113.1% (price as of 2026-08-20) |
| March 3, 2025 | XRAY | P | 15,142 | $16.51 | $249,994 | 81,971 Direct | +22.66% | Acquired | -33.7% (price as of 2026-08-20) |
| Nov. 18, 2024 | XRAY | P | 5,000 | $18.37 | $91,850 | 66,730 Direct | +8.10% | Acquired | -40.4% (price as of 2026-08-20) |
| Nov. 18, 2024 | XRAY | P | 5,000 | $18.37 | $91,850 | 71,730 Direct | +7.49% | Acquired | -40.4% (price as of 2026-08-20) |
| Nov. 15, 2024 | XRAY | P | 1,000 | $18.28 | $18,280 | 21,000 Indirect | +5.00% | Acquired | -40.2% (price as of 2026-08-20) |
| Nov. 15, 2024 | XRAY | P | 1,000 | $18.28 | $18,280 | 16,000 Indirect | +6.67% | Acquired | -40.2% (price as of 2026-08-20) |
| Aug. 8, 2024 | XRAY | P | 8,212 | $24.35 | $199,962 | 66,661 Direct | +14.05% | Acquired | -55.1% (price as of 2026-08-20) |
| May 31, 2024 | XRAY | P | 3,577 | $27.95 | $99,977 | 58,374 Direct | +6.53% | Acquired | -60.9% (price as of 2026-08-20) |
| Nov. 22, 2023 | XRAY | P | 10,000 | $31.44 | $314,400 | 43,121 Direct | +30.19% | Acquired | -65.2% (price as of 2026-08-20) |
| Nov. 15, 2022 | XRAY | P | 6,000 | $31.45 | $188,700 | 15,000 Indirect | +66.67% | Acquired | -65.2% (price as of 2026-08-20) |
| March 4, 2021 | XRAY | P | 9,000 | $58.75 | $528,750 | 9,000 Indirect | — | Acquired | -81.4% (price as of 2026-08-20) |
| March 4, 2021 | XRAY | P | 5,000 | $58.95 | $294,750 | 23,142 Direct | +27.56% | Acquired | -81.4% (price as of 2026-08-20) |
| Nov. 24, 2020 | MRVI | P | 15,000 | $27.00 | $405,000 | 26,852 Direct | +126.56% | Acquired | -70.8% (price as of 2026-08-20) |
| May 23, 2019 | XRAY | P | 10,000 | $53.60 | $536,000 | 10,000 Direct | — | Acquired | -79.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 3, 2026 | XRAY | Stock Option (Right to Buy) | Common Stock (10,900) | — | June 5, 2026 | 10,900 | Acquired |
| June 3, 2026 | XRAY | Stock Option (Right to Buy) | Common Stock (10,900) | $9.64 | June 3, 2036 | 10,900 | Disposed |
| June 3, 2026 | XRAY | Stock Option (Right to Buy) | Common Stock (10,900) | $9.64 | June 3, 2036 | 10,900 | Acquired |
| Oct. 14, 2025 | XRAY | Stock Option (Right to Buy) | Common Stock | $12.96 | Aug. 8, 2035 | 17,200 | Acquired |
| Oct. 14, 2025 | XRAY | Stock Option (Right to Buy) | Common Stock | $12.96 | Aug. 8, 2035 | 17,200 | Disposed |
| Aug. 8, 2025 | XRAY | Stock Option (Right to Buy) | Common Stock (17,200) | $12.96 | Aug. 8, 2035 | 17,200 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).